CIK 0001790340 · <br>Emerging growth company
Immuneering Corp
Sign in to watch- Ticker
- IMRX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 617-500-8080
- Business address
- 245 MAIN STREET, SECOND FLOOR, CAMBRIDGE, MA, 02142
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 43 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-06-14 | Feinberg Peter Director | Grant or award · Stock Option | +17,500 | 17,500 | ||
| 2023-06-14 | CARPENTER ROBERT J Director | Grant or award · Stock Option | +17,500 | 17,500 | ||
| 2023-06-14 | BERMAN ANN E Director | Grant or award · Stock Option | +17,500 | 17,500 | ||
| 2023-06-13 | Morales Mallory VICE PRESIDENT, FINANCE | Grant or award · Stock Option | +15,000 | 15,000 | ||
| 2023-03-31 | Brakewood Harold Eugene Chief Business Officer | Grant or award · Stock Option | +165,000 | 165,000 | ||
| 2023-02-15 | Morales Mallory VICE PRESIDENT, FINANCE | Grant or award · Stock Option | +72,000 | 72,000 | ||
| 2023-02-15 | Neufeld Leah R CHIEF PEOPLE OFFICER | Grant or award · Stock Option | +105,000 | 105,000 | ||
| 2023-02-15 | Hall Brett Matthew CHIEF SCIENTIFIC OFFICER | Grant or award · Stock Option | +187,000 | 187,000 | ||
| 2023-02-15 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +352,244 | 352,244 | ||
| 2023-02-15 | Zeskind Benjamin J. PRESIDENT AND CEO | Grant or award · Stock Option | +21,756 | 374,000 |
Page 8 of 8 · 150 trades